Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy
by Döhner, Hartmut (Author)
, Lübbert, Michael (Author)
, Fiedler, Walter (Author)
, Fouillard, Loic (Author)
, Haaland, Alf (Author)
, Brandwein, Joseph M. (Author)
, Lepretre, Stephane (Author)
, Reman, Oumedaly (Author)
, Turlure, Pascal (Author)
, Ottmann, Oliver G. (Author)
, Müller-Tidow, Carsten (Author)
, Krämer, Alwin (Author)
, Raffoux, Emmanuel (Author)
, Döhner, Konstanze (Author)
, Schlenk, Richard F. (Author)
, Voß, Florian (Author)
, Taube, Tillmann (Author)
, Fritsche, Holger (Author)
, Maertens, Johan (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource